2,3-Dichloro-6,7-dimethoxyquinoxaline - CAS 1790-91-6
Catalog: |
BB013542 |
Product Name: |
2,3-Dichloro-6,7-dimethoxyquinoxaline |
CAS: |
1790-91-6 |
Synonyms: |
2,3-dichloro-6,7-dimethoxyquinoxaline; 2,3-dichloro-6,7-dimethoxyquinoxaline |
IUPAC Name: | 2,3-dichloro-6,7-dimethoxyquinoxaline |
Description: | 2,3-Dichloro-6,7-dimethoxyquinoxaline (CAS# 1790-91-6 ) is a useful research chemical. |
Molecular Weight: | 259.09 |
Molecular Formula: | C10H8Cl2N2O2 |
Canonical SMILES: | COC1=C(C=C2C(=C1)N=C(C(=N2)Cl)Cl)OC |
InChI: | InChI=1S/C10H8Cl2N2O2/c1-15-7-3-5-6(4-8(7)16-2)14-10(12)9(11)13-5/h3-4H,1-2H3 |
InChI Key: | NQGVKCNEXNZDPT-UHFFFAOYSA-N |
Boiling Point: | 337.5 °C at 760 mmHg |
Density: | 1.424 g/cm3 |
LogP: | 2.95380 |
Publication Number | Title | Priority Date |
KR-20180106597-A | Novel [1,2,4]triazolo[4,3-a]quinoxaline amino phenyl derivatives or pharmaceutically acceptable salts thereof, preparation method therof and pharmaceutical composition for use in preventing or treating bromodomain extra-terminal(BET) protein activity related diseases containing the same as an active ingredient | 20170321 |
KR-102070265-B1 | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
KR-20180089298-A | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
US-2020039984-A1 | Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient | 20170126 |
WO-2018139876-A1 | Novel [1,2,4]triazolo[4, 3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating bet protein-related diseases, containing same as active ingredient | 20170126 |
Complexity: | 221 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 257.9962829 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 257.9962829 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 44.2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS